Gallic Acid as a Potential Treatment for Acinetobacter baumannii Infections
Author Information
Author(s): Alturki Mansour S., Al Khzem Abdulaziz H., Gomaa Mohamed S., Tawfeeq Nada, Alhamadah Marwah H., Alshehri Futun M., Alzahrani Raghad, Alghamdi Hanin, Rants’o Thankhoe A., Al Mouslem Abdulaziz K., Almaghrabi Mohammed, Calado Cecília R.C.
Primary Institution: Imam Abdulrahman Bin Faisal University
Hypothesis
Can gallic acid be repurposed as a selective inhibitor of shikimate kinase in Acinetobacter baumannii?
Conclusion
Gallic acid shows promising antibacterial activity against Acinetobacter baumannii and Enterococcus faecalis, making it a potential therapeutic candidate.
Supporting Evidence
- Gallic acid showed very good activity against Acinetobacter baumannii and Enterococcus faecalis in the MIC and MBC assay.
- Gallic acid exhibited better activity against Acinetobacter baumannii due to the overexpression of shikimate kinase.
- The study provides a comprehensive computational and experimental framework for accelerating antimicrobial drug discovery.
Takeaway
Gallic acid, a natural compound, can help fight a superbug called Acinetobacter baumannii by blocking a key enzyme it needs to survive.
Methodology
The study used computational methods like molecular docking and dynamics simulations, followed by experimental validation through MIC and MBC assays.
Limitations
The study lacks in vivo confirmation of findings and does not account for potential resistance development in Acinetobacter baumannii.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website